study was to evaluate complications and survival, focusing on differences between elderly and younger patients undergoing surgery.
Method: Medical charts of 107 surgically treated patients (73 under 70 years and 34 aged 70 years or older) in a tertiary referral center with sinonasal malignancy were retrospectively analyzed. Comorbidity was scored according to the ACE-27 system. Treatment outcomes were analyzed by collecting treatment-related complications scores and survival data.
Results: Although comorbidity was more common in elderly patients, no significant difference was found in complications. In multivariate analysis length of surgery was the only predictor for complication. Furthermore, no significant difference was seen in survival or recurrence of young and elderly patients. Young patients with squamous cell carcinoma and melanoma had a worse overall survival than patients with other histological subtypes. However, in elderly patients no significant difference was detected in survival between histological subtypes.
Conclusion: For complications, survival, and recurrence no difference was seen between young and elderly patients. Therefore, based on this study, elderly sinonasal cancer patients should not be treated differently than younger counterparts.
Head and Neck Surgery
Prognostic impact of Age in Differentiated Thyroid Cancer Samuel L. Oyer, MD (presenter); Valerie A. Smith; Eric J. Lentsch, MD Objective: 1) Determine the impact of age on disease-specific survival in differentiated thyroid cancer. 2) Compare the impact of age on survival between follicular and papillary thyroid cancer subtypes.
Method: The SEER Database was searched for patients with differentiated thyroid cancer between 1988-2003. Patient age, gender, tumor type, size, extension, and metastases were collected. Kaplan-Meier analyses were used to estimate disease specific survival based on age ranges. A multivariate analysis was performed to determine hazard ratios of death for various age cutoffs.
Results: A total of 42,209 patients were identified. Patients 45 years and older had significantly worse survival than younger patients (P < .001). A significant decrease in disease specific survival was first seen in patients aged 35 years and older, and survival continued to steadily decrease with each additional decade of age (P < .001). Patients aged 35 years and older were 14 times more likely to die from differentiated thyroid cancer than patients younger than 35. Age played a stronger prognotic role in death among patients with papillary carcinoma compared to follicular carcinoma.
Conclusion:
Increasing age is associated with poorer survival in differentiated thyroid cancer. This relationship represents a continuum with an initial decrease in survival starting at age 35 that continues to decline with advancing age.
Head and Neck Surgery Revision Thyroid Surgery: Are There More Complications?
Eimear Phelan, MBBCh, MRCSI (presenter); Gregory W. Randolph, MD Objective: To analyze the revision thyroid database of a single thyroid, parathyroid, head and neck surgery institution. To assess whether reoperative thyroid bed surgery is associated with higher postoperative complications.
Method: A retrospective single institutional review over a 5-year period (2004) (2005) (2006) (2007) (2008) (2009) ) was performed by the department of thyroid, parathyroid, head and neck surgery, Massachusetts Eye and Ear Hospital, Boston, MA. IRB approval was obtained. All patients who had revision neck or thyroid bed surgery were included.
Results: A total of 117 cases were included in the study with an average age of 46.2 years. The average follow-up time was 2.5 years. The majority of the patients had papillary thyroid cancer (89.8%). The average number of revision surgeries was 1.5 (range 1-7). The average time between primary surgery and the last revision surgery was 7.3 years (0.1-44.1 years). Approximately 14% of patients had preoperative vocal cord palsy and 18% had preoperative permanent hypocalcemia. No patient developed a new temporary or permanent vocal cord palsy. Five patients developed a temporary and 3 a permanent hypocalcemia.
Conclusion:
These data indicate that a percentage of patients with papillary thyroid cancer who develop recurrent disease will require further revision thyroid surgery. This has generally been accepted to be a more difficult surgery. These data demonstrate that revision thyroid surgery can be a relatively safe procedure with low complications rates.
Head and Neck Surgery Robotic Parathyroidectomy: A Prospective Case Control Study
Asit Arora, AFRCS (presenter); George Garas, MBBS, MRCS; Zaid Awad, MRCS, DOHNS; James Budge; Jeremy Cox; Fausto Palazzo; Neil S.
Tolley, FRCS
Objective: 1) To assess the clinical efficacy and cost-effectiveness of the robotic approach compared with conventional targeted minimally invasive parathyroidectomy. 2) To evaluate whether the absence of a neck scar associated with the robotic approach offers any advantage(s) over conventional targeted minimally invasive parathyroidectomy. 3) To compare patient satisfaction between the 2 techniques.
Method: Prospective case control study of 30 patients that underwent targeted parathyroidectomy over 4 years (May 2009 -February 2012 in a tertiary referral endocrine center. Fifteen patients had a robotic and 15 an endoscopic approach. Outcomes assessed included operative time, blood loss, biochemistry, pain, scar cosmesis, voice, quality of life, and complications.
